Free Trial

Fulgent Genetics (FLGT) SEC Filings & 10K Form

Fulgent Genetics logo
$17.79 -0.63 (-3.42%)
(As of 04:32 PM ET)

Recent Fulgent Genetics SEC Filings

DateFilerForm TypeView
11/08/2024
6:17 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
6:10 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
3:30 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:20 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:21 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:21 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
6:36 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
6:37 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
5:33 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:33 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:33 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:34 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
7:22 PM
Fulgent Genetics (Subject)
Hsieh Ming (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2024
6:38 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
6:09 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:27 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
3:28 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
3:29 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:22 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:22 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
5:04 PM
Fulgent Genetics (Issuer)
Marsh Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
5:05 PM
Fulgent Genetics (Issuer)
GROVES REGINA E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
5:06 PM
Fulgent Genetics (Issuer)
Nohaile Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:29 PM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:21 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:22 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:34 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
6:05 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
3:35 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:07 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Ming Hsieh Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:26 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:28 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:10 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:11 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:11 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:12 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:08 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Free Ebook shares Tesla’s roadmap to $500 a share (Ad)

Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.

To claim your copy, follow this link
02/27/2024
5:50 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:52 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:55 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:48 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:26 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:01 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:39 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
7:49 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
8:43 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
5:00 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
4:47 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
4:54 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
5:12 PM
Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
5:12 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
5:13 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
3:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:30 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
8:21 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
8:21 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FLGT) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners